Trembath P W, Taylor E A, Turner P, Roberts M, Cole P, Amess J
Br J Clin Pharmacol. 1981 Jan;11(1):19-24. doi: 10.1111/j.1365-2125.1981.tb01096.x.
The effects of several β-adrenoceptor antagonists and lignocaine on blood oxyhaemoglobin dissociation curves have been studied in healthy non-smoking subjects. The at 50% saturation () did not significantly change after oral propranolol 80 mg (single dose, and following 2 weeks' administration of 80 mg twice daily), or following separate intravenous injection of propranolol (0.2 mg/kg), practolol (1 mg/kg), atenolol (0.2 mg/kg) and SL 75212 (0.15 and 0.6 mg/kg). Increases in were found after the addition of propranolol 100 and 500 μg/ml, and lignocaine 5 μg/ml to whole blood, but incubation with propranolol at 1000 ng/ml or less, or sotalol 5 and 500 μg/ml and 5 mg/ml resulted in no significant change in . These results suggest that to increase with propranolol requires plasma propranolol concentrations far in excess of concentrations normally achieved, and that the therapeutic effect of propranolol in patients with ischaemic heart disease cannot be attributed to an increase in .
在健康不吸烟受试者中研究了几种β-肾上腺素能受体拮抗剂和利多卡因对血液氧合血红蛋白解离曲线的影响。口服80mg普萘洛尔(单剂量,以及每日两次服用80mg,持续2周后),或分别静脉注射普萘洛尔(0.2mg/kg)、心得宁(1mg/kg)、阿替洛尔(0.2mg/kg)和SL 75212(0.15和0.6mg/kg)后,50%饱和度()时的并未显著改变。向全血中加入100和500μg/ml普萘洛尔以及5μg/ml利多卡因后,有所增加,但与1000ng/ml或更低浓度的普萘洛尔、5和500μg/ml以及5mg/ml索他洛尔孵育后,未发生显著变化。这些结果表明,普萘洛尔要增加,所需的血浆普萘洛尔浓度远远超过通常达到的浓度,且普萘洛尔对缺血性心脏病患者的治疗作用不能归因于的增加。